Abstract
Summary
According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period.
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contraceptives. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contraceptives market.
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Key Features:
The report on Contraceptives market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Contraceptives market. It may include historical data, market segmentation by Type (e.g., Pills, Injectable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contraceptives market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contraceptives market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Contraceptives industry. This include advancements in Contraceptives technology, Contraceptives new entrants, Contraceptives new investment, and other innovations that are shaping the future of Contraceptives.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contraceptives market. It includes factors influencing customer ' purchasing decisions, preferences for Contraceptives product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contraceptives market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contraceptives market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contraceptives market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contraceptives industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contraceptives market.
Market Segmentation:
Contraceptives market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Segmentation by type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Segmentation by end user
15–24 years
25–34 years
35–44 years
Above 44 years
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptives market?
What factors are driving Contraceptives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptives market opportunities vary by end market size?
How does Contraceptives break out type, end user?
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contraceptives. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contraceptives market.
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Key Features:
The report on Contraceptives market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Contraceptives market. It may include historical data, market segmentation by Type (e.g., Pills, Injectable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contraceptives market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contraceptives market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Contraceptives industry. This include advancements in Contraceptives technology, Contraceptives new entrants, Contraceptives new investment, and other innovations that are shaping the future of Contraceptives.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contraceptives market. It includes factors influencing customer ' purchasing decisions, preferences for Contraceptives product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contraceptives market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contraceptives market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contraceptives market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contraceptives industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contraceptives market.
Market Segmentation:
Contraceptives market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Segmentation by type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Segmentation by end user
15–24 years
25–34 years
35–44 years
Above 44 years
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptives market?
What factors are driving Contraceptives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptives market opportunities vary by end market size?
How does Contraceptives break out type, end user?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contraceptives Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Contraceptives by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Contraceptives by Country/Region, 2019, 2023 & 2030
2.2 Contraceptives Segment by Type
2.2.1 Pills
2.2.2 Injectable
2.2.3 Condoms
2.2.4 Vaginal Rings
2.2.5 IUDs
2.2.6 Subdermal Implants
2.2.7 Others
2.3 Contraceptives Sales by Type
2.3.1 Global Contraceptives Sales Market Share by Type (2019-2024)
2.3.2 Global Contraceptives Revenue and Market Share by Type (2019-2024)
2.3.3 Global Contraceptives Sale Price by Type (2019-2024)
2.4 Contraceptives Segment by End User
2.4.1 15–24 years
2.4.2 25–34 years
2.4.3 35–44 years
2.4.4 Above 44 years
2.5 Contraceptives Sales by End User
2.5.1 Global Contraceptives Sale Market Share by End User (2019-2024)
2.5.2 Global Contraceptives Revenue and Market Share by End User (2019-2024)
2.5.3 Global Contraceptives Sale Price by End User (2019-2024)
3 Global Contraceptives by Company
3.1 Global Contraceptives Breakdown Data by Company
3.1.1 Global Contraceptives Annual Sales by Company (2019-2024)
3.1.2 Global Contraceptives Sales Market Share by Company (2019-2024)
3.2 Global Contraceptives Annual Revenue by Company (2019-2024)
3.2.1 Global Contraceptives Revenue by Company (2019-2024)
3.2.2 Global Contraceptives Revenue Market Share by Company (2019-2024)
3.3 Global Contraceptives Sale Price by Company
3.4 Key Manufacturers Contraceptives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptives Product Location Distribution
3.4.2 Players Contraceptives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Contraceptives by Geographic Region
4.1 World Historic Contraceptives Market Size by Geographic Region (2019-2024)
4.1.1 Global Contraceptives Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Contraceptives Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Contraceptives Market Size by Country/Region (2019-2024)
4.2.1 Global Contraceptives Annual Sales by Country/Region (2019-2024)
4.2.2 Global Contraceptives Annual Revenue by Country/Region (2019-2024)
4.3 Americas Contraceptives Sales Growth
4.4 APAC Contraceptives Sales Growth
4.5 Europe Contraceptives Sales Growth
4.6 Middle East & Africa Contraceptives Sales Growth
5 Americas
5.1 Americas Contraceptives Sales by Country
5.1.1 Americas Contraceptives Sales by Country (2019-2024)
5.1.2 Americas Contraceptives Revenue by Country (2019-2024)
5.2 Americas Contraceptives Sales by Type
5.3 Americas Contraceptives Sales by End User
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptives Sales by Region
6.1.1 APAC Contraceptives Sales by Region (2019-2024)
6.1.2 APAC Contraceptives Revenue by Region (2019-2024)
6.2 APAC Contraceptives Sales by Type
6.3 APAC Contraceptives Sales by End User
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Contraceptives by Country
7.1.1 Europe Contraceptives Sales by Country (2019-2024)
7.1.2 Europe Contraceptives Revenue by Country (2019-2024)
7.2 Europe Contraceptives Sales by Type
7.3 Europe Contraceptives Sales by End User
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Contraceptives by Country
8.1.1 Middle East & Africa Contraceptives Sales by Country (2019-2024)
8.1.2 Middle East & Africa Contraceptives Revenue by Country (2019-2024)
8.2 Middle East & Africa Contraceptives Sales by Type
8.3 Middle East & Africa Contraceptives Sales by End User
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptives
10.3 Manufacturing Process Analysis of Contraceptives
10.4 Industry Chain Structure of Contraceptives
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptives Distributors
11.3 Contraceptives Customer
12 World Forecast Review for Contraceptives by Geographic Region
12.1 Global Contraceptives Market Size Forecast by Region
12.1.1 Global Contraceptives Forecast by Region (2025-2030)
12.1.2 Global Contraceptives Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Contraceptives Forecast by Type
12.7 Global Contraceptives Forecast by End User
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Contraceptives Product Portfolios and Specifications
13.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Pfizer, Inc
13.2.1 Pfizer, Inc Company Information
13.2.2 Pfizer, Inc Contraceptives Product Portfolios and Specifications
13.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer, Inc Main Business Overview
13.2.5 Pfizer, Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Merck & Co., Inc
13.4.1 Merck & Co., Inc Company Information
13.4.2 Merck & Co., Inc Contraceptives Product Portfolios and Specifications
13.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck & Co., Inc Main Business Overview
13.4.5 Merck & Co., Inc Latest Developments
13.5 Actavis, Inc.
13.5.1 Actavis, Inc. Company Information
13.5.2 Actavis, Inc. Contraceptives Product Portfolios and Specifications
13.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Actavis, Inc. Main Business Overview
13.5.5 Actavis, Inc. Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Contraceptives Product Portfolios and Specifications
13.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Gedeon Richter
13.7.1 Gedeon Richter Company Information
13.7.2 Gedeon Richter Contraceptives Product Portfolios and Specifications
13.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gedeon Richter Main Business Overview
13.7.5 Gedeon Richter Latest Developments
13.8 Novo Nordisk A/S
13.8.1 Novo Nordisk A/S Company Information
13.8.2 Novo Nordisk A/S Contraceptives Product Portfolios and Specifications
13.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Novo Nordisk A/S Main Business Overview
13.8.5 Novo Nordisk A/S Latest Developments
13.9 ZiZhu
13.9.1 ZiZhu Company Information
13.9.2 ZiZhu Contraceptives Product Portfolios and Specifications
13.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 ZiZhu Main Business Overview
13.9.5 ZiZhu Latest Developments
13.10 Baijingyu
13.10.1 Baijingyu Company Information
13.10.2 Baijingyu Contraceptives Product Portfolios and Specifications
13.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Baijingyu Main Business Overview
13.10.5 Baijingyu Latest Developments
13.11 Huazhong
13.11.1 Huazhong Company Information
13.11.2 Huazhong Contraceptives Product Portfolios and Specifications
13.11.3 Huazhong Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Huazhong Main Business Overview
13.11.5 Huazhong Latest Developments
13.12 Sine
13.12.1 Sine Company Information
13.12.2 Sine Contraceptives Product Portfolios and Specifications
13.12.3 Sine Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sine Main Business Overview
13.12.5 Sine Latest Developments
13.13 Reckitt
13.13.1 Reckitt Company Information
13.13.2 Reckitt Contraceptives Product Portfolios and Specifications
13.13.3 Reckitt Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Reckitt Main Business Overview
13.13.5 Reckitt Latest Developments
13.14 AbbVie
13.14.1 AbbVie Company Information
13.14.2 AbbVie Contraceptives Product Portfolios and Specifications
13.14.3 AbbVie Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 AbbVie Main Business Overview
13.14.5 AbbVie Latest Developments
13.15 Church & Dwight
13.15.1 Church & Dwight Company Information
13.15.2 Church & Dwight Contraceptives Product Portfolios and Specifications
13.15.3 Church & Dwight Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Church & Dwight Main Business Overview
13.15.5 Church & Dwight Latest Developments
13.16 The Cooper Companies
13.16.1 The Cooper Companies Company Information
13.16.2 The Cooper Companies Contraceptives Product Portfolios and Specifications
13.16.3 The Cooper Companies Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 The Cooper Companies Main Business Overview
13.16.5 The Cooper Companies Latest Developments
13.17 TherapeuticsMD
13.17.1 TherapeuticsMD Company Information
13.17.2 TherapeuticsMD Contraceptives Product Portfolios and Specifications
13.17.3 TherapeuticsMD Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 TherapeuticsMD Main Business Overview
13.17.5 TherapeuticsMD Latest Developments
13.18 Afaxys
13.18.1 Afaxys Company Information
13.18.2 Afaxys Contraceptives Product Portfolios and Specifications
13.18.3 Afaxys Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Afaxys Main Business Overview
13.18.5 Afaxys Latest Developments
13.19 Mithra Pharmaceuticals
13.19.1 Mithra Pharmaceuticals Company Information
13.19.2 Mithra Pharmaceuticals Contraceptives Product Portfolios and Specifications
13.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Mithra Pharmaceuticals Main Business Overview
13.19.5 Mithra Pharmaceuticals Latest Developments
14 Research Findings and Conclusion